https://www.reuters.com/article/health-coronavirus-astrazeneca-vaccine-idUSKBN27B0J1

16 0

LONDON (Reuters) - One of the world’s leading COVID-19 experimental vaccines produces a immune response in both young and old adults, raising hopes of a path out of the gloom and economic destruction wrought by the novel coronavirus. FILE PHOTO: A test tube labeled with the vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020. REUTERS/Dado Ruvic/File Photo. The vaccine, developed by the University of Oxford, also triggers lower adverse responses among the elderly, British drug maker AstraZeneca Plc, which is helping manufacture the vaccine, said on Monday. A vaccine that works is seen as a game-changer in the battle against the novel coronavirus, which... Full story

26 October

wait